ACRV
BFLY

Mary Miller

Known title: Chief Legal OfficerCIK: 0001841088

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 15, 2026

Acrivon Therapeutics noted among health‑care stocks moving in after‑market. Acrivon Therapeutics (ACRV) was included in a Benzinga roundup of twelve health‑care stocks that showed price movement during Wednesday’s after‑market session. The mention signals recent trading activity after regular hours. The stock is currently near its 52‑week low and its RSI is below 40, suggesting limited momentum.

this person other insiders at ACRV

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Butterfly Network Announces Long‑Term Alliance with VCOM and Gains New Coverage. Butterfly Network entered a long‑term partnership with the Edward Via College of Osteopathic Medicine to develop a new ultrasound education model. The collaboration aims to expand training tools for medical students. In addition, Canaccord Genuity started coverage on the stock, setting a price target of $10. The move reflects growing interest in Butterfly’s technology and its educational applications.

this person other insiders at BFLY

Transaction History

ACRV▼ Sell$585
ACRV▼ Sell$372
ACRV▼ Sell$1K
ACRV▲ Buy$0
ACRV▼ Sell$353
ACRV▼ Sell$993
ACRV▼ Sell$354
ACRV▼ Sell$1K
ACRV▼ Sell$412
ACRV▼ Sell$1K
ACRV▼ Sell$514
ACRV▼ Sell$256
ACRV▼ Sell$737
ACRV▼ Sell$210
ACRV▼ Sell$1K
ACRV▼ Sell$1K
ACRV▼ Sell$4K
ACRV▼ Sell$1K
ACRV▼ Sell$4K
ACRV▼ Sell$2K
ACRV▼ Sell$1K
ACRV▼ Sell$4K
ACRV▼ Sell$2K
ACRV▼ Sell$6K
ACRV▼ Sell$738
ACRV▼ Sell$3K
ACRV▼ Sell$4K
ACRV▼ Sell$12K
ACRV▲ Buy$0
BFLY▲ Buy$0
BFLY▲ Buy$0
BFLY▼ Sell$99K

We use analytics to understand how market-wall is used. No personal data is sold.